Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Journal of Medicinal Chemistry
|
May 5, 2000
Corticotropin releasing factor (CRF) receptor modulators: progress and opportunities for new therapeutic agents
P J Gilligan, D W Robertson, R Zaczek
The Journal of Membrane Biology
|
June 28, 1978
Kinetic analysis of the inhibition of sulfate transport in human red blood cells by isothiocyanates
E T Rakitzis, P J Gilligan, J F Hoffman
Npj Computational Materials
|
April 26, 2024
A rule-free workflow for the automated generation of databases from scientific literature
Luke P J Gilligan, Matteo Cobelli, Valentin Taufour, et al.
Journal of Medicinal Chemistry
|
February 4, 1994
Piperidinyltetralin sigma ligands
P J Gilligan, A A Kergaye, B M Lewis, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1992
DuP 734 [1-(cyclopropylmethyl)-4-(2'(4''-fluorophenyl)-2'-oxoethyl)- piperidine HBr], a sigma and 5-hydroxytryptamine2 receptor antagonist: receptor-binding, electrophysiological and neuropharmacological profiles
S W Tam, G F Steinfels, P J Gilligan, et al.
Bioorganic & Medicinal Chemistry
|
January 13, 2000
Structure-activity studies on 4-substituted-2-anilinopyrimidine corticotropin releasing factor (CRF) antagonists
P J Gilligan, L He, S Culp, et al.
Clinical Radiology
|
April 18, 2020
Respirators and surgical facemasks for COVID-19: implications for MRI
O M Murray, J M Bisset, P J Gilligan, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 18, 1999
Thiazolo[4,5-d]pyrimidine thiones and -ones as corticotropin-releasing hormone (CRH-R1) receptor antagonists
J P Beck, M A Curry, R J Chorvat, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 7, 1999
4-Aryl-2-anilinopyrimidines as corticotropin-releasing hormone (CRH) antagonists
A J Cocuzza, F W Hobbs, C R Arnold, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 7, 1999
Purin-8-ones as corticotropin-releasing hormone (CRH-R1) receptor antagonists
J P Beck, A G Arvanitis, M A Curry, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Journal of Medicinal Chemistry
|
May 5, 2000
Corticotropin releasing factor (CRF) receptor modulators: progress and opportunities for new therapeutic agents
P J Gilligan, D W Robertson, R Zaczek
The Journal of Membrane Biology
|
June 28, 1978
Kinetic analysis of the inhibition of sulfate transport in human red blood cells by isothiocyanates
E T Rakitzis, P J Gilligan, J F Hoffman
Npj Computational Materials
|
April 26, 2024
A rule-free workflow for the automated generation of databases from scientific literature
Luke P J Gilligan, Matteo Cobelli, Valentin Taufour, et al.
Journal of Medicinal Chemistry
|
February 4, 1994
Piperidinyltetralin sigma ligands
P J Gilligan, A A Kergaye, B M Lewis, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1992
DuP 734 [1-(cyclopropylmethyl)-4-(2'(4''-fluorophenyl)-2'-oxoethyl)- piperidine HBr], a sigma and 5-hydroxytryptamine2 receptor antagonist: receptor-binding, electrophysiological and neuropharmacological profiles
S W Tam, G F Steinfels, P J Gilligan, et al.
Bioorganic & Medicinal Chemistry
|
January 13, 2000
Structure-activity studies on 4-substituted-2-anilinopyrimidine corticotropin releasing factor (CRF) antagonists
P J Gilligan, L He, S Culp, et al.
Clinical Radiology
|
April 18, 2020
Respirators and surgical facemasks for COVID-19: implications for MRI
O M Murray, J M Bisset, P J Gilligan, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 18, 1999
Thiazolo[4,5-d]pyrimidine thiones and -ones as corticotropin-releasing hormone (CRH-R1) receptor antagonists
J P Beck, M A Curry, R J Chorvat, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 7, 1999
4-Aryl-2-anilinopyrimidines as corticotropin-releasing hormone (CRH) antagonists
A J Cocuzza, F W Hobbs, C R Arnold, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 7, 1999
Purin-8-ones as corticotropin-releasing hormone (CRH-R1) receptor antagonists
J P Beck, A G Arvanitis, M A Curry, et al.
Page
of 2